These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31257573)

  • 21. Oral challenge with a methionine load in patients with inflammatory bowel disease: a better test to identify hyperhomocysteinemia.
    Zepeda-Gómez S; Montano-Loza A; Zapata-Colindres JC; Vargas-Vorackova F; Majluf-Cruz A; Uscanga L
    Inflamm Bowel Dis; 2008 Mar; 14(3):383-8. PubMed ID: 17924554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
    Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):869-73. PubMed ID: 26083986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of statin therapy with the risk of recurrent venous thrombosis.
    Smith NL; Harrington LB; Blondon M; Wiggins KL; Floyd JS; Sitlani CM; McKnight B; Larson EB; Rosendaal FR; Heckbert SR; Psaty BM
    J Thromb Haemost; 2016 Jul; 14(7):1384-92. PubMed ID: 27061794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
    Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
    Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study.
    Timp JF; Lijfering WM; Flinterman LE; van Hylckama Vlieg A; le Cessie S; Rosendaal FR; Cannegieter SC
    J Thromb Haemost; 2015 Oct; 13(10):1823-32. PubMed ID: 26270389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.
    Oldenburg B; Van Tuyl BA; van der Griend R; Fijnheer R; van Berge Henegouwen GP
    Dig Dis Sci; 2005 Feb; 50(2):235-40. PubMed ID: 15745078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma homocysteine cutoff values for venous thrombosis.
    Castañon MM; Lauricella AM; Kordich L; Quintana I
    Clin Chem Lab Med; 2007; 45(2):232-6. PubMed ID: 17311514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Male-specific risk of first and recurrent venous thrombosis: a phylogenetic analysis of the Y chromosome.
    de Haan HG; van Hylckama Vlieg A; van der Gaag KJ; de Knijff P; Rosendaal FR
    J Thromb Haemost; 2016 Oct; 14(10):1971-1977. PubMed ID: 27495181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
    Naess IA; Christiansen SC; Romundstad PR; Cannegieter SC; Blom HJ; Rosendaal FR; Hammerstrøm J
    Br J Haematol; 2008 May; 141(4):529-35. PubMed ID: 18318759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow-up study.
    Morelli VM; Lijfering WM; Rosendaal FR; Cannegieter SC
    J Thromb Haemost; 2017 Apr; 15(4):695-701. PubMed ID: 28135040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 894 G > T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels.
    Heil SG; Den Heijer M; Van Der Rijt-Pisa BJ; Kluijtmans LA; Blom HJ
    J Thromb Haemost; 2004 May; 2(5):750-3. PubMed ID: 15099281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
    Hainaut P; Jaumotte C; Verhelst D; Wallemacq P; Gala JL; Lavenne E; Heusterspreute M; Zech F; Moriau M
    Thromb Res; 2002 Apr; 106(2):121-5. PubMed ID: 12182910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
    Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No added value of the methionine loading task in assessment for venous thrombosis and cardiovascular disease risk.
    Keijzer MB; Verhoef P; Borm GF; Blom HJ; den Heijer M
    Thromb Haemost; 2006 Feb; 95(2):380-5. PubMed ID: 16502562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: a case report.
    Costea A; Bhat G
    Am J Hematol; 2004 Oct; 77(2):161-3. PubMed ID: 15389901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
    Timp JF; Lijfering WM; Rosendaal FR; le Cessie S; Cannegieter SC
    J Thromb Haemost; 2019 Sep; 17(9):1527-1534. PubMed ID: 31188515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cysteine and homocysteine in venous and arterial thrombotic disease.
    Marcucci R; Brunelli T; Giusti B; Fedi S; Pepe G; Poli D; Prisco D; Abbate R; Gensini GF
    Am J Clin Pathol; 2001 Jul; 116(1):56-60. PubMed ID: 11447752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.